Detailed stratified GWAS analysis for severe COVID-19 in four European populations
ABSTRACT
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our understanding of underlying disease mechanisms. Here, we describe an extended GWAS meta-analysis of a well-characterized cohort of 3,260 COVID-19 patients with respiratory failure and 12,483 population controls from Italy, Spain, Norway and Germany/Austria, including stratified analyses based on age, sex and disease severity, as well as targeted analyses of chromosome Y haplotypes, the human leukocyte antigen (HLA) region and the SARS-CoV-2 peptidome. By inversion imputation, we traced a reported association at 17q21.31 to a highly pleiotropic ∼0.9-Mb inversion polymorphism and characterized the potential effects of the inversion in detail. Our data, together with the 5th release of summary statistics from the COVID-19 Host Genetics Initiative, also identified a new locus at 19q13.33, including NAPSA, a gene which is expressed primarily in alveolar cells responsible for gas exchange in the lung.
Competing Interest Statement
Details of competing interests are given in the manuscript.
Funding Statement
Details of funding are given in the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Details of all oversight bodies are given in the manuscript.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
Additional details of the analyses may be requested from the corresponding authors and data will be shared per the authors approval.
ABBREVIATIONS
- 95%CI
- 95% confidence interval
- AT1
- Type 1 alveolar cells
- AT2
- Type 2 alveolar cells
- CAD
- Coronary artery disease
- CHRH1
- Corticotropin Releasing Hormone Receptor 1
- COVID-19
- Coronavirus disease 2019
- COVID-19 HGI
- COVID-19 Host Genetics Initiative
- DAMPs
- Damage-associated transient progenitors
- DNA
- Deoxyribonucleic acid
- ECMO
- Extracorporeal membrane oxygenation
- eQTL
- Expression quantitative trait loci
- FISH
- Fluorescence in situ hybridization
- FMNL1
- Formin Like 1
- GenOMICC
- Genetics Of Mortality In Critical Care Initiative
- GSA
- Global Screening Array
- GTEx
- Genotype-Tissue Expression project
- GWAS
- Genome-wide association analysis
- HLA
- Human Leukocyte Antigen
- KANSL1
- KAT8 Regulatory NSL Complex Subunit 1
- KCNC3
- Potassium Voltage-Gated Channel Subfamily C Member 3
- LD
- Linkage disequilibrium
- MAF
- Minor allele frequency
- MAPT
- Microtubule Associated Protein Tau
- Mb
- Megabase pairs
- NAPSA
- Napsin A Aspartic Peptidase
- NES
- normalized effect size
- NR1H2
- Nuclear Receptor Subfamily 1 Group H Member 2
- OR
- Odds ratio
- P
- P-value of association
- PCA
- Principal component analysis
- PCR
- Polymerase-chain reaction
- PepWAS
- Peptidome-wide association study
- PheWAS
- Phenome wide association study
- PPR
- Posterior probability of replication
- QC
- Quality control
- RNA
- Ribonucelic acid
- RNA-seq
- RNA sequencing
- scRNA-seq
- Single sell RNA-seq
- SNP
- Single nucleotide Polymorphism
- sQTL
- Quantitative splicing trait loci
Subject Area
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)